JNK As a Biomarker of Relapse and Response to Treatment with Glatiramer Acetate in Multiple Sclerosis

被引：0
|
作者：
Anselmo, Freidrich [1 ]
Tatomir, Alexandru [1 ]
Ciriello, Jonathan [1 ]
Rus, Horea [2 ]
机构：
[1] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[2] Vet Adm Multiple Sclerosis Ctr Excellence East, Baltimore, MD USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P016
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [21] Spasticity in multiple sclerosis and role of glatiramer acetate treatment
    Eustasio Meca-Lallana, Jose
    Hernandez-Clares, Rocio
    Carreon-Guarnizo, Ester
    BRAIN AND BEHAVIOR, 2015, 5 (09):
  • [22] Glatiramer Acetate Treatment of Multiple Sclerosis: An Immunological Perspective
    Racke, Michael K.
    Lovett-Racke, Amy E.
    JOURNAL OF IMMUNOLOGY, 2011, 186 (04): : 1887 - 1890
  • [23] Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis
    Bourdette, Dennis
    Hartung, Daniel
    JAMA NEUROLOGY, 2015, 72 (12) : 1411 - 1413
  • [24] Multiple sclerosis relapse rates and healthcare costs of two versions of glatiramer acetate
    Greenberg, Benjamin
    Hall, Steven
    Grabner, Michael
    Balu, Sanjeev
    Zhang, Xian
    Kantor, Daniel
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (07) : 1167 - 1175
  • [25] JNK and phosphorylated Bcl-2 predict multiple sclerosis clinical activity and glatiramer acetate therapeutic response
    Anselmo, Freidrich
    Tatomir, Alexandru
    Boodhoo, Dallas
    Mekala, Armugam P.
    Vinh Nguyen
    Rus, Violeta
    Rus, Horea
    CLINICAL IMMUNOLOGY, 2020, 210
  • [26] Immunogenetic predictors of response to glatiramer acetate therapy in multiple sclerosis
    Valenzuela, Reuben Mari
    Buyske, Steven
    Ito, Kouichi
    Dhib-Jalbut, Suhayl
    MULTIPLE SCLEROSIS, 2009, 15 (11): : 1407 - 1407
  • [27] Metabolic response to glatiramer acetate therapy in multiple sclerosis patients
    De Riccardis, Lidia
    Ferramosca, Alessandra
    Danieli, Antonio
    Trianni, Giorgio
    Zara, Vincenzo
    De Robertis, Francesca
    Maffia, Michele
    BBA CLINICAL, 2016, 6 : 131 - 137
  • [28] Treatment Challenges in Multiple Sclerosis - A Continued Role for Glatiramer Acetate?
    Mirabella, Massimiliano
    Annovazzi, Pietro
    Brownlee, Wallace
    Cohen, Jeffrey A.
    Kleinschnitz, Christoph
    Wolf, Christian
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [29] Glatiramer acetate in multiple sclerosis: A review
    Ruggieri, Maddalena
    Avolio, Carlo
    Livrea, Paolo
    Trojano, Maria
    CNS DRUG REVIEWS, 2007, 13 (02): : 178 - 191
  • [30] Lipoatrophy associated with glatiramer acetate injections for the treatment of multiple sclerosis
    Hwang, L
    Orengo, I
    CUTIS, 2001, 68 (04): : 287 - 288
12345